{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T04:05:10Z","timestamp":1789790710410,"version":"4.0.1"},"reference-count":9,"publisher":"Japanese Society of Internal Medicine","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026]]},"DOI":"10.2169\/internalmedicine.7898-26","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T22:11:44Z","timestamp":1789423904000},"source":"Crossref","is-referenced-by-count":0,"title":["Pulmonary Inflammatory Myofibroblastic Tumor Mimicking Septic Pulmonary Embolism Following a Dental Infection"],"prefix":"10.2169","author":[{"given":"Yohei","family":"Kanzawa","sequence":"first","affiliation":[{"name":"Department of General Internal Medicine, Akashi Medical Center, Japan"},{"name":"Department of General Internal Medicine, Kobe University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuya","family":"Sano","sequence":"additional","affiliation":[{"name":"Department of Pathology, Akashi Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masataka","family":"Ono","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, Akashi Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimpei","family":"Mizuki","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, Akashi Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Nakajima","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, Akashi Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Ishimaru","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, Akashi Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Gleason BC, Hornick JL. Inflammatory myofibroblastic tumours: where are we now? J Clin Pathol 1: 428-437, 2008.","DOI":"10.1136\/jcp.2007.049387"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Coffin CM, Hornick JL, Fletcher CDM. Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases. Am J Surg Pathol 31: 509-520, 2007.","DOI":"10.1097\/01.pas.0000213393.57322.c7"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Eldaabossi S, Almaghrabi R, Alghamdi M, et al. Common presentation of uncommon disease: inflammatory myofibroblastic tumor of the lung, case report. Respir Med Case Rep 37: 101656, 2022.","DOI":"10.1016\/j.rmcr.2022.101656"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Valerio L, Baddour LM. Septic pulmonary embolism: a contemporary profile. Semin Thromb Hemost 49: 840-847, 2023.","DOI":"10.1055\/s-0042-1758742"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Kwon WJ, Jeong YJ, Kim KI, et al. Computed tomographic features of pulmonary septic emboli: comparison of causative microorganisms. J Comput Assist Tomogr 31: 390-394, 2007.","DOI":"10.1097\/01.rct.0000243455.23308.a9"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Tong D, Chisholm J, Madden B, Ahmed M. Anaplastic lymphoma kinase-positive pulmonary inflammatory myofibroblastic tumour: a case report. J Med Case Rep 18: 167, 2024.","DOI":"10.1186\/s13256-024-04472-9"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Li M, Xing R, Huang J, et al. Case report: epithelioid inflammatory myofibroblastic sarcoma treated with an ALK TKI ensartinib. Front Oncol 13: 1084456, 2023.","DOI":"10.3389\/fonc.2023.1084456"},{"key":"8","unstructured":"8. Chugai Pharmaceutical Co., Ltd. Alecensa receives the world-first tumor-agnostic approval for ALK fusion gene-positive solid tumors across adult and pediatric patients [Internet]. Press release. 2026 May 18. Available from: https:\/\/www.chugai-pharm.co.jp\/english\/news\/detail\/20260518153001_1249.html"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Arakawa A, Hirakawa A, Kohsaka S, et al. Efficacy and safety of alectinib in pediatric and adult patients with ALK altered advanced solid tumors: results from the TACKLE phase II trial, a MASTER KEY substudy (NCCH1712\/MK003). J Clin Oncol 43(16_suppl): 3105, 2025.","DOI":"10.1200\/JCO.2025.43.16_suppl.3105"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_7898-26\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T03:30:58Z","timestamp":1789788658000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_7898-26\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":9,"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.7898-26","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"7898-26"}}